Progress in Nanomedicine: Approved and Investigational Nanodrugs.

By C. L. Ventola. P & T : a peer-reviewed journal for formulary management, 2017

711 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Smart Nanoparticles for Drug Delivery Application: Development of Versatile Nanocarrier Platforms in Biotechnology and Nanomedicine (2019, background): “While a number of nanocarrier-based platforms have been approved for the treatment of various diseases (including tumors), many others are in different phases of clinical trials [9, 10].”
Nano based drug delivery systems: recent developments and future prospects (2018, background): “, a closer cooperation among regulatory agencies is warranted [204, 251].”
The Therapeutic Potential of Nanobodies (2019, background): “Passive targeting employs the increased vascular permeability and retention effect, as well as the poor lymphatic drainage to achieve drug accumulation into the tumour microenvironment [3, 27, 28].”
Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles’ Physicochemical Properties on Responses in Biological Systems (2023, background): “Tricor (AbbVie, Chicago, IL, USA) Fenofibrate Oral administration Hyper-lipidemia 1998 [41]”